Managing bacterial meningitis in childrenUpdated statement outlines empiric antimicrobial therapy and clarifies the role of corticosteroids. Alemtuzumab for multiple sclerosis rejected by U.S. FDANeurologists divided over the FDA’s decision. Lemtrada: new treatment for relapsing remitting MS Two treatment courses reduce relapse risk and disability accumulation. Updated Canadian statement on the use of herpes zoster vaccine New statement provides clarity on several controversial issues. Alzheimer risk starts early Aubagio: new oral therapy for MS Drug approved for use as a monotherapy to reduce the frequency of clinical exacerbations, delay accumulation of physical disability. Chewing gum causing migraines? Israeli study suggests gum may be causing headaches in teens. Drug hits Parkinson’s psychosis Two drugs better than one in secondary stroke prevention Researchers recommend dual antiplatelet therapy over monotherapy CADTH Corner: Preventing stroke in patients with atrial fibrillation—what about ASA? First Previous 32 33 34 35 36 Next Last
